Abstract

A comprehensive review of studies published through July 2021 has found limited evidence supporting the use of cannabis or cannabinoids in the treatment of psychiatric disorders. The strongest evidence for use of cannabinoids appears to be for the management of chronic pain. Results were published online Dec. 8, 2021, in the American Journal of Psychiatry.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call